95%Confidence
0Views
FDASource
2026-03-03Date
Summary
Third Asteria Health testosterone recall reveals contamination issues across multiple dosage strengths. This pattern indicates serious manufacturing deficiencies requiring comprehensive corrective actions.
Actionable: Blacklist Asteria Health as a supplier until FDA confirms resolution of all manufacturing deficiencies.
AI Confidence: 95%
Data Points
firmF.H. INVESTMENTS, Inc. (dba Asteria Health)
classificationClass II
statusOngoing
distributionNationwide in the USA
productTestosterone, 25.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1025-32.
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now